Sentence examples for multiple centres involved from inspiring English sources

Multiple centres involved from a variety of countries.

Although multiple centres were involved most of these were specialist, and recruitment was unequally distributed, introducing a risk of geographical or centre-specific bias.

Questions on the form related to: any blinding and in particular double blinding; the numbers of active and placebo/control arms; whether multiple centres were involved (sometimes deduced from the number of institutional review boards mentioned); the target and actual sample sizes; and any justification given for the target sample size.

Indeed, all the diagnostic centres involved in the study were general radiology departments dealing with a very wide range of clinical conditions, resulting in the adoption of various CT protocols that can significantly differ in radiation dose for several reasons (i.e. because of a lower target image noise and/or multiple post-contrast acquisitions) [19, 20, 21, 22].

The patients were stratified according to the different centres involved.

71 Eight studies involved multiple centres.

Four of six cohorts recruited participants from multiple centres, while two (Hong Kong and Spain) involved only a single centre.

Multiple centres per country were involved and included university hospitals and office-based physicians; however, it is uncertain whether the clinical centres included in AURA are fully representative of patient management in the entire country.

Since it involved multiple centres, the drug was acquired in usual care, there were very few inclusion/exclusion criteria and many patients were on other background DMARDs at the time of ETN initiation where the non-MTX DMARDs were discontinued, the results are very generalisable.

In general, large studies involving multiple centres are more feasible if they require minimal changes from current practice.

Qualification, defined as a "graded, fit-for-purpose evidentiary process linking a biomarker with biological processes and clinical end-points", is a validation process in large cohorts of patients involving multiple centres, similar to phase III clinical trials, to obtain regulatory approval as surrogate endpoints [4].